MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
EUR 134.2
(-0.26%)
EUR 134.2
(-0.26%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 6.50 EUR | -15.03% |
| 2022 | 7.65 EUR | 8.82% |
| 2021 | 7.03 EUR | 53.83% |
| 2020 | 4.57 EUR | 50.33% |
| 2019 | 3.04 EUR | -60.82% |
| 2018 | 7.76 EUR | 29.55% |
| 2017 | 5.99 EUR | 59.73% |
| 2016 | 3.75 EUR | 46.48% |
| 2015 | 2.56 EUR | -3.76% |
| 2014 | 2.66 EUR | -3.97% |
| 2013 | 2.77 EUR | 111.45% |
| 2012 | 1.31 EUR | -6.43% |
| 2011 | 1.40 EUR | -4.11% |
| 2010 | 1.46 EUR | 73.81% |
| 2009 | 0.84 EUR | -1.18% |
| 2008 | 0.85 EUR | -89.52% |
| 2007 | 8.11 EUR | 219.29% |
| 2006 | 2.54 EUR | 52.1% |
| 2005 | 1.67 EUR | -2.34% |
| 2004 | 1.71 EUR | 200.0% |
| 2003 | 0.57 EUR | -1.72% |
| 2002 | 0.58 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 1.40 EUR | -12.5% |
| 2024 Q1 | 1.60 EUR | 18.52% |
| 2023 Q1 | 1.83 EUR | 21.19% |
| 2023 Q2 | 1.62 EUR | -11.48% |
| 2023 FY | - EUR | -15.03% |
| 2023 Q4 | 1.35 EUR | -20.59% |
| 2023 Q3 | 1.70 EUR | 4.94% |
| 2022 FY | - EUR | 8.82% |
| 2022 Q1 | 2.02 EUR | 9.19% |
| 2022 Q2 | 1.99 EUR | -1.49% |
| 2022 Q4 | 1.51 EUR | -28.77% |
| 2022 Q3 | 2.12 EUR | 6.53% |
| 2021 Q3 | 1.75 EUR | 2.34% |
| 2021 Q4 | 1.85 EUR | 5.71% |
| 2021 FY | - EUR | 53.83% |
| 2021 Q1 | 1.72 EUR | 72.0% |
| 2021 Q2 | 1.71 EUR | -0.58% |
| 2020 FY | - EUR | 50.33% |
| 2020 Q1 | 1.05 EUR | 43.84% |
| 2020 Q2 | 0.67 EUR | -36.19% |
| 2020 Q3 | 1.85 EUR | 176.12% |
| 2020 Q4 | 1.00 EUR | -45.95% |
| 2019 Q4 | 0.73 EUR | -7.59% |
| 2019 Q1 | 0.43 EUR | -92.34% |
| 2019 Q2 | 1.08 EUR | 151.16% |
| 2019 Q3 | 0.79 EUR | -26.85% |
| 2019 FY | - EUR | -60.82% |
| 2018 Q4 | 5.61 EUR | 619.23% |
| 2018 Q2 | 0.57 EUR | -26.92% |
| 2018 Q1 | 0.78 EUR | -66.38% |
| 2018 FY | - EUR | 29.55% |
| 2018 Q3 | 0.78 EUR | 36.84% |
| 2017 Q3 | 1.48 EUR | 51.02% |
| 2017 Q2 | 0.98 EUR | -18.33% |
| 2017 Q1 | 1.20 EUR | 93.55% |
| 2017 FY | - EUR | 59.73% |
| 2017 Q4 | 2.32 EUR | 56.76% |
| 2016 Q1 | 1.36 EUR | 368.97% |
| 2016 Q4 | 0.62 EUR | -40.95% |
| 2016 Q3 | 1.05 EUR | 45.83% |
| 2016 Q2 | 0.72 EUR | -47.06% |
| 2016 FY | - EUR | 46.48% |
| 2015 Q2 | 0.79 EUR | 21.54% |
| 2015 FY | - EUR | -3.76% |
| 2015 Q4 | 0.29 EUR | -65.48% |
| 2015 Q3 | 0.84 EUR | 6.33% |
| 2015 Q1 | 0.65 EUR | 1.56% |
| 2014 Q4 | 0.64 EUR | 12.28% |
| 2014 FY | - EUR | -3.97% |
| 2014 Q1 | 0.75 EUR | 17.19% |
| 2014 Q2 | 0.70 EUR | -6.67% |
| 2014 Q3 | 0.57 EUR | -18.57% |
| 2013 Q2 | 0.73 EUR | 19.67% |
| 2013 FY | - EUR | 111.45% |
| 2013 Q4 | 0.64 EUR | -17.95% |
| 2013 Q3 | 0.78 EUR | 6.85% |
| 2013 Q1 | 0.61 EUR | -3.17% |
| 2012 FY | - EUR | -6.43% |
| 2012 Q1 | 0.40 EUR | 25.0% |
| 2012 Q2 | -0.14 EUR | -135.0% |
| 2012 Q4 | 0.63 EUR | 46.51% |
| 2012 Q3 | 0.43 EUR | 407.14% |
| 2011 Q2 | -0.19 EUR | -124.05% |
| 2011 Q3 | 0.52 EUR | 373.68% |
| 2011 Q4 | 0.32 EUR | -38.46% |
| 2011 FY | - EUR | -4.11% |
| 2011 Q1 | 0.79 EUR | 690.0% |
| 2010 Q4 | 0.10 EUR | -79.59% |
| 2010 FY | - EUR | 73.81% |
| 2010 Q3 | 0.49 EUR | 16.67% |
| 2010 Q1 | 0.44 EUR | 238.46% |
| 2010 Q2 | 0.42 EUR | -4.55% |
| 2009 Q1 | 0.13 EUR | 0.0% |
| 2009 Q2 | 0.25 EUR | 92.31% |
| 2009 FY | - EUR | -1.18% |
| 2009 Q3 | 0.33 EUR | 32.0% |
| 2009 Q4 | 0.13 EUR | -60.61% |
| 2008 FY | - EUR | -89.52% |
| 2007 FY | - EUR | 219.29% |
| 2006 FY | - EUR | 52.1% |
| 2005 FY | - EUR | -2.34% |
| 2004 FY | - EUR | 200.0% |
| 2003 FY | - EUR | -1.72% |
| 2002 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| MPH Health Care AG | 6.90 EUR | 5.797% |
| Apontis Pharma AG | -1.33 EUR | 588.722% |
| Dermapharm Holding SE | 1.16 EUR | -460.345% |
| Evotec SE | -0.47 EUR | 1482.979% |
| PharmaSGP Holding SE | 1.37 EUR | -374.453% |
| SynBiotic SE | -2.24 EUR | 390.179% |